Nitric oxide-peroxynitrite-poly(ADP-ribose) polymerase pathway in the skin

Experimental Dermatology

Volumn 11, Issue 3, 2002, Pages 189-202

  Virág, László ^a   Szabó, Éva ^a,b   Bakondi, Edina ^a   Bai, Péter ^a   Gergely, Pál ^a   Hunyadi, János ^a   Szabó, Csaba ^b  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b Inotek Inc   (United States)

Author keywords

Inflammation; Keratinocyte; Nitric oxide; Peroxynitrite; Poly(ADP ribose) polymerase; Skin

Indexed keywords

ARGININE; MATRIX METALLOPROTEINASE INHIBITOR; NICOTINAMIDE ADENINE DINUCLEOTIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE INHIBITOR; NITRIC OXIDE; NITRIC OXIDE DONOR; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; PEROXYNITRITE; RETINOIC ACID DERIVATIVE; SUPEROXIDE; OXIDIZING AGENT; PEROXYNITROUS ACID; POLY(ADENOSINE DIPHOSPHATE RIBOSE);

BURN; CELL DEATH; CONTACT ALLERGY; CONTACT DERMATITIS; DNA STRAND BREAKAGE; DOSE RESPONSE; DRUG CYTOTOXICITY; DRUG EFFECT; DRUG HALF LIFE; DRUG INHIBITION; DRUG POTENTIATION; DRUG TARGETING; ENZYME ACTIVATION; ERYTHEMA; HISTOPATHOLOGY; HUMAN; IRRITANT DERMATITIS; ISCHEMIA; MELANOGENESIS; NONHUMAN; PHARMACOLOGICAL PARAMETERS; PHYSIOLOGY; PSORIASIS; REGULATORY MECHANISM; REPERFUSION INJURY; REVIEW; SHOCK; SIDE EFFECT; SKIN BLOOD FLOW; SKIN DISEASE; SKIN INFECTION; SKIN INFLAMMATION; SUNBURN; TISSUE INJURY; ULTRAVIOLET RADIATION; WOUND HEALING; ANIMAL; ENZYMOLOGY; FUNCTIONS OF THE SKIN AND ITS APPENDAGES; METABOLISM; SKIN;

ANIMALS; HUMANS; NITRIC OXIDE; OXIDANTS; PEROXYNITROUS ACID; POLY ADENOSINE DIPHOSPHATE RIBOSE; POLY(ADP-RIBOSE) POLYMERASES; SKIN; SKIN PHYSIOLOGY;

EID: 0036616978     PISSN: 09066705     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0625.2002.110301.x     Document Type: Review

References (171)

1. Bruch-Gerhanz D, Ruzicka T, Kolb-Bachofen V. Nitric oxide in human skin: Current status and future prospects. J Invest Dermatol 1998: 110: 1-7.
2. Weller R. Nitric oxide - A newly discovered chemical transmitter in human skin. Br J Dermatol 1997: 137: 665-672.
3. Weller R. Nitric oxide, skin growth and differentiation: More questions than answers? Clin Exp Dermatol 1999: 24: 388-391.
4. Ignarro L J, Buga G M, Wood K S, Byrns R E, Chaudhuri G. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci U S A 1987: 84: 9265-9269.
5. Palmer R M, Ferrige A G, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987: 327: 524-526.
6. Beckman J S, Koppenol Wh. Nitric oxide, superoxide, and peroxynitrite: The good, the bad, and ugly. Am J Physiol 1996: 271: C1424-C1437.
7. Szabo C. The pathophysiological role of peroxynitrite in shock, inflammation, and ischemia-reperfusion injury. Shock 1996: 6: 79-88.
8. Marletta M A, Hurshman A R, Rusche K M. Catalysis by nitric oxide synthase. Curr Opin Chem Biol 1998: 2: 656-663.
9. Arnold W P, Mittal C K, Katsuki S, Murad F. Nitric oxide activates guanylate cyclase and increases guanosine 3′: 5′ - cyclic monophosphate levels in various tissue preparations. Proc Natl Acad Sci U S A 1977: 74: 3203-3207.
10. Nathan C. Inducible nitric oxide synthase: What difference does it make? J Clin Invest 1997: 100: 2417-2423.
11. Ghafourifar P, Richter C. Nitric oxide synthase activity in mitochondria. FEBS Lett 1997: 418: 291-296.
12. Richter C, Schweizer M, Ghafourifar P. Mitochondria, nitric oxide, and peroxynitrite. Method Enzymol 1999: 301: 381-393.
13. Weller R, Pattullo S, Smith L, Golden M, Ormerod A, Benjamin N. Nitric oxide is generated on the skin surface by reduction of sweat nitrate. J Invest Dermatol 1996: 107: 327-331.
14. Feron O. Endothelial nitric oxide synthase expression and its functionality. Curr Opin Clin Nutr Metab Care 1999: 2: 291-296.
15. Warren J B. Nitric oxide and human skin blood flow responses to acetylcholine and ultraviolet light. FASEB J 1994: 8: 247-251.
16. Arany I, Brysk M M, Brysk H, Tyring S K. Regulation of inducible nitric oxide synthase mRNA levels by differentiation and cytokines in human keratinocytes. Biochem Biophys Res Commun 1996: 220: 618-622.
17. Qureshi A A, Hosoi J, Xu S, Takashima A, Granstein R D, Lerner E A. Langerhans cells express inducible nitric oxide synthase and produce nitric oxide. J Invest Dermatol 1996: 107: 815-821.
18. Wang R, Ghahary A, Shen Y J, Scott P G, Tredget E E. Human dermal fibroblasts produce nitric oxide express both constitutive and inducible nitric oxide synthase isoforms. J Invest Dermatol 1996: 106: 419-427.
19. Rocha I M, Guillo L A. Lipopolysaccharide and cytokines induce nitric oxide synthase and produce nitric oxide in cultured normal human melanocytes. Arch Dermatol Res 2001: 293: 245-248.
20. Tsatmali M, Manning P, McNeil CJ, Thody A J. Alpha-MSH inhibits lipopolysaccharide induced nitric oxide production in B16 mouse melanoma cells. Ann N Y Acad Sci 1999: 885: 474-476.
21. Deliconstantinos G, Villiotou V, Stravrides J C. Release by ultraviolet B (u.v. B) radiation of nitric oxide (NO) from human keratinocytes: A potential role for nitric oxide in erythema production. Br J Pharmacol 1995: 114: 1257-1265.
22. Deliconstantinos G, Villiotou V, Stavrides J C. Alterations of nitric oxide synthase and xanthine oxidase activities of human keratinocytes by ultraviolet B radiation. Potential role for peroxynitrite in skin inflammation. Biochem Pharmacol 1996: 51: 1727-1738.
23. Kolb-Bachofen V, Fehsel K, Michel G, Ruzicka T. Epidermal keratinocyte expression of inducible nitric oxide synthase in skin lesions of psoriasis vulgaris. Lancet 1994: 344: 139.
24. Morhenn V B. Langerhans cells may trigger the psoriatic disease process via production of nitric oxide. Immunol Today 1997: 18: 433-436.
25. Ormerod A D, Weller R, Copeland P et al. Detection of nitric oxide and nitric oxide synthases in psoriasis. Arch Dermatol Res 1998: 290: 3-8.
26. Sirsjo A, Karlsson M, Gidlof A, Rollman O, Torma H. Increased expression of inducible nitric oxide synthase in psoriatic skin and cytokine-stimulated cultured keratinocytes. Br J Dermatol 1996: 134: 643-648.
27. Ross R, Gillitzer C, Kleinz R et al. Involvement of NO in contact hypersensitivity. Int Immunol 1998: 10: 61-69.
28. Morita H, Hori M, Kitano Y. Modulation of picryl chloride-induced contact hypersensitivity reaction in mice by nitric oxide. J Invest Dermatol 1996: 107: 549-552.
29. Akcay M N, Ozcan O, Gundogdu C et al. Effect of nitric oxide synthase inhibitor on experimentally induced brain wounds. J Trauma 2000: 49: 327-330.
30. Efron DT, Most D, Barbul A. Role of nitric oxide in wound healing. Curr Opin Clin Nutr Metab Care 2000: 3: 197-204.
31. Schaffer M R, Tantry U, Gross S S, Wasserburg H L, Barbul A. Nitric oxide regulates wound healing. J Surg Res 1996: 63: 237-240.
32. Shi H P, Efron D T, Most D, Tantry U S, Barbul A. Supplemental dietary arginine enhances wound healing in normal but not inducible nitric oxide synthase knockout mice. Surgery 2000: 128: 374-378.
33. Stallmeyer B, Kampfer H, Kolb N, Pfeilschifter J, Frank S. The function of nitric oxide in wound repair: Inhibition inducible nitric oxide-synthase severely impairs wound reepithelialization. J Invest Dermatol 1999: 113: 1090-1098.
34. Yamasaki K, Edington H D, McClosky C et al. Reversal of impaired wound repair in iNOS-deficient mice by tropical adenoviral-mediated iNOS gene transfer. J Clin Invest 1998: 101: 967-971.
35. Becker W K, Shippee R L, McManus A T, Mason A D Jr, Pruitt B A Jr Kinetics of nitrogen oxide production following experimental thermal injury in rats. J Trauma 1993: 34: 855-862.
36. Carter E A, Derojas-Walker T, Tamir S, Tannenbaum S R, Yu Y M, Tompkins R G. Nitric oxide production is intensely and persistently increased in tissue by thermal injury. Biochem J 1994: 304: 201-204.
37. Smith D J, Dunphy M J, Strag L N, Marletta M A. The influence of wound healing on urinary nitrate levels in rats. Wounds 1991: 3: 50-55.
38. Albina J E, Mills C D, Henry W L Jr, Caldwell M D. Temporal expression of different pathways of 1-arginine metabolism in healing wounds. J Immunol 1990: 144: 3877-3880.
39. Shabani M M, Pulfer S K, Bulgrin J P, Smith D J. Enhancement of wound repair with a topically applied nitric oxide-releasing polymer. Wound Repair Regen 1996: 4: 353-359.
40. Groves J T. Peroxynitrite: Reactive, invasive and enigmatic. Curr Opin Chem Biol 1999: 3: 226-235.
41. Fridovich I. Fundamental aspects of reactive oxygen species, or what's the matter with oxygen? Ann N Y Acad Sci 1999: 893: 13-18.
42. MacMillan-Crow L A, Crow J P, Thompson J A. Peroxynitrate-mediated inactivation of manganese superoxide dismutase involes nitration and oxidation of critical tyrosine residues. Biochemistry 1998: 37: 1613-1622.
43. Radi R, Beckman J S, Bush K M, Freeman B A. Peroxynitrite oxidative of sulfhydryls. The cytotoxic potential of superoxide and nitric oxide. J Biol Chem 1991: 266: 4244-4250.
44. Radi R, Beckman J S, Bush K M, Freeman B A. Peroxynitrite-induced membrane lipid peroxidation: The cytotoxic potential of superoxide and nitric oxide. Arch Biochem Biophys 1991: 288: 481-487.
45. Salgo M G, Stone K, Squadrito G L, Battista J R, Pryor W A. Peroxynitrite causes DNA nicks in plasmid pBR322. Biochem Biophys Res Commun 1995: 210: 1025-1030.
46. Go Y M, Patel R P, Maland M C et al. Evidence for peroxynitrite as a signaling molecule in flow-dependent activation of c-Jun NH (2)-terminal kinase. Am J Physiol 1999: 277: H1647-H1653.
47. Klotz L O, Schieke S M, Sies H, Holbrook N J. Peroxynitrite activates the phosphoinositide 3-kinase/Akt pathway in human skin primary fibroblasts. Biochem J 2000: 352 Part 1: 219-225.
48. Mallozzi C, Di Stasi A M, Minetti M. Activation of src tyrosine kinases by peroxynitrite. FEBS Lett 1999: 456: 201-206.
49. Oh-Hashi K, Maruyama W, Yi H, Takahashi T, Naoi M, Isobe K. Mitogen-activated protein kinase pathway mediates peroxynitrite-induced apoptosis in human dopaminergic neuroblastoma SH-SY5Y cells. Biochem Biophys Res Commun 1999: 263: 504-509.
50. Schieke S M, Briviba K, Klotz L O, Sies H. Activation pattern of mitogen-activated protein kinases elicited by peroxynitrite: Attenuation by selenite supplementation. FEBS Lett 1999: 448: 301-303.
51. Palomba L, Sestili P, Guidarelli A et al. Products of the phospholipase A (2) pathway mediate the dihydrorhodamine fluorescence response evoked by endogenous and exogenous peroxynitrite in PC12 cells. Free Radic Biol Med 2000: 29: 783-789.
52. Perrin D, Koppenol Wh. The quantitative oxidation of methionine to methionine sulfoxide by peroxynitrite. Arch Biochem Biophys 2000: 377: 266-272.
53. Viner R I, Williams T D, Schoneich C. Peroxynitrite modification of protein thiols, oxidation, nitrosylation, and S-glutathiolation of functionally important cysteine residue (s) in the sarcoplasmic reticulum Ca-ATPase. Biochemistry 1999: 38 : 12408-12415.
54. Kuhn D M, Aretha C W, Geddes T J. Peroxynitrite inactivation of tyrosine hydroxylase: Mediation by sulfhydryl oxidation, not tyrosine nitration. J Neurosci 1999: 19: 10289-10294.
55. Kuhn D M, Geddes T J. Peroxynitrite inactivates tryptophan hydroxylase via sulfhydryl oxidation. Coincident nitration of enzyme tyrosyl residues has minimal impact on catalytic activity. J Biol Chem 1999: 274: 29726-29732.
56. Stepien K, Zajdel A, Wilczok A et al. Dopamine-melanin protects against tyrosine nitration, tryptophan oxidation and Ca (2+)-ATPase inactivation induced by peroxynitrite. Biochim Biophys Acta 2000: 1523: 189-195.
57. Zhang H, Joseph J, Feix J, Hogg N, Kalyanaraman B. Nitration and oxidation of a hydrophobic tyrosine probe by peroxynitrite in membranes: Comparison with nitration and oxidation of tyrosine by peroxynitrite in aqueous solution. Biochemistry 2001: 40: 7675-7686.
58. Tien M, Berlett B S, Levine R L, Chock P B, Stadtman E R. Peroxynitrite-mediated modification of proteins at physiological carbon dioxide concentration: pH dependence of carbonyl formation, tyrosine nitration, and methionine oxidation. Proc Natl Acad Sci U S A 1999: 96: 7809-7814.
59. Berlett B S, Levine R L, Stadtman E R. Carbon dioxide stimulates peroxynitrite-mediated nitration of tyrosine residues and inhibits oxidation of methionine residues of glutamine synthetase. Both modifications mimic effects of adenylylation. Proc Natl Acad Sci U S A 1998: 95: 2784-2789.
60. Alvarez B, Rubbo H, Kirk M, Barnes S, Freeman B A, Radi R. Peroxynitrite-dependent tryptophan nitration. Chem Res Toxicol 1996: 9: 390-396.
61. Beckman J S. Oxidative damage and tyrosine nitration from peroxynitrite. Chem Res Toxicol 1996: 9: 836-844.
62. Crow J P, Beckman J S. Reactions between nitric oxide, superoxide, and peroxynitrite: Footprints of peroxynitrite in vivo. Adv Pharmacol 1995: 34: 17-43.
63. Gow A J, Duran D, Malcolm S, Ischiropoulos H. Effects of peroxynitrite-induced protein modifications on tyrosine phosphorylation and degradation. FEBS Lett 1996: 385: 63-66.
64. Kong S K, Yim M B, Stadtman E R, Chock P B. Peroxynitrite disables the tyrosine phosphorylation regulatory mechanism: Lymphocyte-specific tyrosine kinase fails to phosphorylate nitrated cdc: 2(6-20): NH2 peptide. Proc Natl Acad Sci U S A 1996: 93: 3377-3382.
65. Gow A, Duran D, Thom S R, Ischiropoulos H. Carbon dioxide enhancement of peroxynitrite-mediated protein tyrosine nitration. Arch Biochem Biophys 1996: 333: 42-48.
66. Uppu R M, Squadrito G L, Pryor W A. Acceleration of peroxynitrite oxidations by carbon dioxide. Arch Biochem Biophys 1996: 327: 335-343.
67. Crow J P, Ischiropoulos H. Detection and quantitation of nitrotyrosine residues in proteins: In vivo marker of peroxynitrite. Methods Enzymol 1996: 269: 185-194.
68. Ischiropoulos H, Zhu L, Chen J et al. Peroxynitrite-mediated tyrosine nitration catalyzed by superoxide dismutase. Arch Biochem Biophys 1992: 298: 431-437.
69. Eiserich J P, Hristova M, Cross C E et al. Formation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils. Nature 1998: 391: 393-397.
70. Sampson J B Ye Y, Rosen H, Beckman J S. Myeloperoxidase and horseradish peroxidase catalyze tyrosine nitration in proteins from nitrite and hydrogen peroxide. Arch Biochem Biophys 1998: 356: 207-213.
71. Eiserich J P, Cross C E, Jones A D, Halliwell B, Van Der Vliet A. Formation of nitrating and chlorinating species by reaction of nitrite with hypochlorous acid. A novel mechanism for nitric oxide-mediated protein modification. J Biol Chem 1996: 271: 19199-19208.
72. Guittet O, Ducastel B, Salem J S et al. Differential sensitivity of the tyrosyl radical of mouse ribonucleotide reductase to nitric oxide and peroxynitrite. J Biol Chem 1998: 273: 22136-22144.
73. Gunther M R, Hsi L C, Curtis J F et al. Nitric oxide trapping of the tyrosyl radical of prostaglandin H synthase-2 leads to tyrosine iminoxyl radical and nitrotyrosine formation. J Biol Chem 1997: 272: 17086-17090.
74. Greenacre S A, Evans P, Halliwell B, Brain S D. Formation and loss of nitrated proteins in peroxynitrite-treated rat skin in vivo. Biochem Biophys Res Commun 1999: 262: 781-786.
75. Rawlingson A, Greenacre S A, Brain S D. Generation of peroxynitrite in localised, moderate temperature burns. Burns 2000: 26: 223-227.
76. Hattori Y, Nishigori C, Tanaka T et al. 8-hydroxy-2′-deoxyguanosine is increased in epidermal cells of hairless mice after chronic ultraviolet B exposure. J Invest Dermatol 1996: 107: 733-737.
77. Giorgio S, Linares E, Capurro M, De Bianchi A G, Augusto O. Formation of nitrosyl hemoglobin and nitrotyrosine during murine leishmaniasis. Photochem Photobiol 1996: 63: 750-754.
78. Um S C, Suzuki S, Toyokuni S, Uchida K, Hiai H, Nishimura Y. Formation of 4-hydroxy-2-nonenal-modified proteins and 3-nitro-L- tyrosine in rat island skin flaps during and after ischemia. Ann Plast Surg 1999: 42: 293-298.
79. Cotton S A, Herrick A L, Jayson M I, Freemont A J. Endothelial expression of nitric oxide synthases and nitrotyrosine in systemic sclerosis skin. J Pathol 1999: 189: 273-278.
80. Ormerod A D, Copeland P, Hay I, Husain A, Ewen S W. The inflammatory and cytotoxic effects of a nitric oxide releasing cream on normal skin. J Invest Dermatol 1999: 113: 392-397.
81. Szabo E, Virag L, Bakondi E et al. Peroxynitrite production, DNA breakage, and poly (ADP-ribose) polymerase activation in a mouse model of oxazolone-induced contact hypersensitivity. J Invest Dematol 2001: 117: 74-80.
82. Deliconstantinos G, Villiotou V, Stavrides J C. Increase of particulate nitric oxide synthase activity and peroxynitrite synthesis in UVB-irradiated keratinocyte membranes. Biochem J 1996: 320: 997-1003.
83. Deliconstantinos G, Villiotou V, Stavrides J C. Nitric oxide and peroxynitrite released by ultraviolet B-irradiated human endothelial cells are possibly involved in skin erythema and inflammation. Exp Physiol 1996: 81: 1021-1033.
84. Deliconstantinos G, Villiotou V, Stavrides J C. Inhibition of ultraviolet B-induced skin erythema by N-nitro-1-arginine and N-monomethyl-1-arginine. J Dermatol Sci 1997: 15: 23-35.
85. Radi R, Peluffo G, Alvarez M N, Naviliat M, Cayota A. Unraveling peroxynitrite formation in biological systems. Free Radic Biol Med 2001: 30: 463-488.
86. Marla S S, Lee J, Groves J T. Peroxynitrite rapidly permeates phospholipid membranes. Proc Natl Acad Sci U S A 1997: 94: 14243-14248.
87. Denicola A, Souza J M, Radi R. Diffusion of peroxynitrite across erythrocyte membranes. Proc Natl Acad Sci U S A 1998: 95: 3566-3571.
88. Lizasoain I, Moro M A, Knowles R G, Darley-Usmar V, Moncada S. Nitric oxide and peroxynitrite exert distinct effects on mitochondrial respiration which are differentially blocked by glutathione or glucose. Biochem J 1996: 314: 877-880.
89. Stamler J S. Redox signaling: Nitrosylation and related target interactions of nitric oxide. Cell 1994: 78: 931-936.
90. Liu L, Stamler J S, An inhibitor of cell death. Cell Death Differ 1999: 6: 937-942.
91. Melino G, Bernassola F, Knight R A, Corasaniti M T, Nistico G, Finazzi-Agro A. S-nitrosylation regulates apoptosis. Nature 1997: 388: 432-433.
92. Brune B, Von Knethen A, Sandau K B. Nitric oxide (NO): An effector of apoptosis. Cell Death Differ 1999: 6: 969-975.
93. Dimmeler S, Zeiher A M. Nitric oxide and apoptosis: Another paradigm for the double-edged role of nitric oxide. Nitric Oxide 1997: 1: 275-281.
94. Estevez A G, Radi R, Barbeito L, Shin J T, Thompson J A, Beckman J S. Peroxynitrite-induced cytotoxicity in PC12 cells: Evidence for an apoptotic mechanism differentially modulated by neurotrophic factors. J Neurochem 1995: 65: 1543-1550.
95. Salgo M G, Squadrito G L, Pryor W A. Peroxynitrite causes apoptosis in rat thymocytes. Biochem Biophys Res Commun 1995: 215: 1111-1118.
96. Virág L, Marmer D J, Szabó C. Crucial role of apopain in the peroxynitrite-induced apoptotic DNA fragmentation. Free Radic Biol Med 1998: 25: 1075-1082.
97. Virág L, Scott G S, Cuzzocrea S, Marmer D, Salzman A, Szabó C. Peroxynitrite-induced thymocyte apoptosis. The role of caspases and poly (ADP-ribose) synthetase (PARS) activation. Immunology 1998: 94: 345-355.
98. Rubbo H, Radi R, Trujillo M et al. Nitric oxide regulation of superoxide and peroxynitrite-dependent lipid peroxidation. Formation of novel nitrogen-containing oxidized lipid derivatives. J Biol Chem 1994: 269: 26066-26075.
99. Landino L M, Crews B C, Timmons M D, Morrow J D, Marnett L J. Peroxynitrite, the coupling product of nitric oxide and superoxide, activates prostaglandin biosynthesis. Proc Natl Acad Sci USA 1996: 93: 15069-15074.
100. Fujimoto Y, Tagano S, Ogawa K, Sakuma S, Fujita T. Comparison of the effects of nitric oxide and peroxynitrite on the 12-lipoxygenase and cyclooxygenase metabolism of arachidonic acid in rabbit platelets. Prostaglandins Leukot Essent Fatty Acids 1998: 59: 95-100.
101. Adrie C, Richter C, Bachelet M et al. Contrasting effects of NO and peroxynitrites on HSP70 expression and apoptosis in human monocytes. Am J Physiol Cell Physiol 2000: 279: C452-C460.
102. Kubes P, Suzuki M, Granger D N. Nitric oxide: An endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci U S A 1991: 88: 4651-4655.
103. Zouki C, Zhang S L, Chan J S, Filep J G. Peroxynitrite induces integrin-dependent adhesion of human neutrophils to endothelial cells via activation of the Raf-1/MEK/Erk pathway. FASEB J 2001: 15: 25-27.
104. Okamoto T, Akaike T, Nagano T, et al. Activation of human neutrophil procollagenase by nitrogen dioxide and peroxynitrite: A novel mechanism for procollagenase activation involving nitric oxide. Arch Biochem Biophy 1997: 342: 261-274.
105. Rajagopalan S, Meng X P, Ramasamay S, Harrison D G, Galis Z S. Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. Implications for atherosclerotic plaque stability. J Clin Invest 1996: 98: 2572-2579.
106. Owens M W, Milligan S A, Jourd'heuil D, Grisham M B. Effects of reactive metabolites of oxygen and nitrogen on gelatinase A activity. Am J Physiol 1997: 273: L445-L450.
107. Frears E R, Zhang Z, Blake D R, O'Connell J P, Winyard P G. Inactivation of tissue inhibitor of metalloproteinase-1 by peroxynitrite. FEBS Lett 1996: 381: 21-24.
108. Radomski M W, Palmer R M, Moncada S. Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium. Lancet 1987: 2: 1057-1058.
109. Moro MA, Darley-Usmar V M, Goodwin D A et al. Paradoxical fate and biological action of peroxynitrite on human platelets. Proc Natl Acad Sci U S A 1994: 91: 6702-6706.
110. Brown A S, Moro M A, Masse J M, Cramer E M, Radomski M, Darley-Usmar V. Nitric oxide-dependent and independent effects on human platelets treated with peroxynitrite. Cardiovasc Res 1998: 40: 380-388.
111. Monosova E E, Kirsch M, Rauen U, De Groot H. The critical role of Hepes in SIN-1 cytotoxicity, peroxynitrite versus hydrogen peroxide. Free Radic Biol Med 1998: 24: 522-528.
112. Moro M A, Darley-Usmar V M, Lizasoain I et al. The formation of nitric oxide donors from peroxynitrite. Br J Pharmacol 1995: 116: 1999-2004.
113. Szabó C, Zingarelli B, O'Connor M, Salzan A L. DNA strand breakage, activation of poly (ADP-ribose) synthetase, and cellular energy depletion are involved in the cytotoxicity of macrophages and smooth muscle cells exposed to peroxynitrite. Proc Natl Acad Sci U S A 1996: 93: 1753-1758.
114. De Murcia G, Menissier-De Murcia J. Poly (ADP-ribose) polymerase: A molecular nick sensor. Trends Biochem Sci 1994: 19: 172.
115. Le Rhun Y, Kirkland J B, Shah G M. Cellular responses to DNA damage in the absence of Poly (ADP-ribose) polymerase. Biochem Biophys Res Commun 1998: 245: 1-10.
116. Kannan P, Yu Y, Wankhade S, Tainsky M A. PolyADP-ribose polymerase is a coactivator for AP-2-mediate transcriptional activation. Nucleic Acids Res 1999: 27: 866-874.
117. Meisterernst M, Stelzer G, Roeder R G. Poly (ADP-ribose) polymerase enhances activator-dependent transcription in vitro. Proc Natl Acad Sci U S A 1997: 94: 2261-2265.
118. Simbulan-Rosenthal C M, Ly Dh, Rosenthal D S et al. Misregulation of gene expression in primary fibroblasts lacking poly (ADP-ribose) polymerase. Proc Natl Acad Sci U S A 2000: 97: 11274-11279.
119. Soriano G F, Virág L, Jagtap P et al. Diabetic endothelial dysfunction: The role of poly (ADP-ribose) polymerase activation. Nat Med 2001: 7: 108-113.
120. Szabó C, Dawson V L. Role of poly (ADP-ribose) synthetase in inflammation and ischaemia-reperfusion. Trends Pharmacol Sci 1998: 19: 287-298.
121. Hinshaw D B, Lodhi I J, Hurley L L, Atkins K B, Dabrowska M I. Activation of poly [ADP-Ribose] polymerase in endothelial cells and keratinocytes: Role in an in vitro model of sulfur mustard-mediated vesication. Toxicol Appl Pharmacol 1999: 156: 17-29.
122. Lippe I T, Stabentheiner A, Holzer P. Participation of nitric oxide in the mustard oil-induced neurogenic inflammation of the rat paw skin. Eur J Pharmacol 1993: 232: 113-120.
123. Filipovic D M, Meng X, Reeves W B. Inhibition of PARP prevents oxidant-induced necrosis but not apoptosis in LLC-PK1 cells. Am J Physiol 1999: 277: F428-F436.
124. Ha H C, Snyder Sh. Poly (ADP-ribose) polymerase is a mediator of necrotic cell death by ATP depletion. Proc Natl Acad Sci U S A 1999: 96: 13978-13982.
125. Lerner Lh, Qureshi A A, Reddy B V, Lerner E A. Nitric oxide synthase in toxic epidermal necrolysis and Stevens-Johnson syndrome. J Invest Dermatol 2000: 114: 196-199.
126. Maccubbin A E, Przybyszewski J, Evans M S et al. DNA damage in UVB-irradiated keratinocytes. Carcinogenesis 1995: 16: 1659-1660.
127. Virág L. The role of PARP in the immune system. In: Szabó C, ed. Cell Death: The Role of PARP. Boca Raton, FL: CRC Press, 2000: 131-166.
128. Butler A J, Ordahl C P. (ADP-ribose) polymerase binds with transcription enhancer factor 1 to MCAT1 elements to regulate muscle-specific transcription. Mol Cell Biol 1999: 19: 296-306.
129. Rawling J M, Alvarez-Gonzalez R. TFIIF, a basal eukaryotic transcription factor, is a substrate for poly (ADP-ribosyl)ation. Biochem J 1997: 324: 249-253.
130. Szabó C, Virág L, Cuzzocrea S et al. Protection against peroxynitrite-induced fibroblast injury and arthritis development by inhibition of poly (ADP-ribose) synthase. Proc Natl Acad Sci U S A 1998: 95: 3867-3872.
131. Zingarelli B, Salzman A L, Szabó C. Genetic disruption of poly (ADP-ribose) synthetase inhibits the expression of P-selectin and intercellular adhesion molecule-1 in myocardial ischemia/reperfusion injury. Circ Res 1998: 83: 85-94.
132. Miyamoto T, Kakizawa T, Hashizume K. Inhibition of nuclear receptor signalling by poly (ADP-ribose) polymerase. Mol Cell Biol 1999: 19: 2644-2649.
133. Ame J C, Rolli V, Schreiber V et al. PARP-2, a novel mammalian DNA damage-dependent poly (ADP-ribose) polymerase. J Biol Chem 1999: 274: 17860-17868.
134. Kickhoefer V A, Siva A C, Kedersha N L et al. The 193-kD vault protein, VPARP, is a novel poy (ADP-ribose) polymerase. J Cell Biol 1999: 146: 917-928.
135. Smith S, Giriat I, Schmitt A, De Lange T. Tankyrase, a poly (ADP-ribose) polymerase at human telomeres. Science 1998: 282: 1484-1487.
136. Kinsella J P, Neish S R, Shaffer E, Abman Sh. Low-dose inhalation nitric oxide in persistent pulmonary hypertension of the newborn. Lancet 1992: 340: 819-820.
137. Roberts J D, Polaner D M, Lang P, Zapol W M. Inhaled nitric oxide in persistent pulmonary hypertension of the newborn. Lancet 1992: 340: 818-819.
138. Chabrier P E, Demerle-Pallardy C, Auguet M. Nitric oxide synthases: Targets for therapeutic strategies in neurological diseases. Cell Mol Life Sci 1999: 55: 1029-1035.
139. Szabó C. Alterations in nitric oxide production in various forms of circulatory shock. New Horiz 1995: 3: 2-32.
140. Vincent J L, Zhang H, Szabo C, Preiser J C. Effects of nitric oxide in septic shock. Am J Respir Crit Care Med 2000: 161: 1781-1785.
141. Weller R, Ormerod A D, Hobson R P, Benjamin N J. A randomized trial of acidified nitrite cream in the treatment of tinea pedis. J Am Acad Dermatol 1998: 38: 559-563.
142. Ormerod A D, White M I, Shah S A, Benjamin N. Molluscum contagiosum effectively treated with a topical acidified nitrite, nitric oxide liberating cream. Br J Dermatol 1999: 141: 1051-1053.
143. Weller R, Dykhuizen R, Leifert C, Ormerod A. Nitric oxide release accounts for the reduced incidence of cutaneous infections in psoriasis. J Am Acad Dermatol 1997: 36: 281-282.
144. Szabó C, Southan G J, Thiemermann C. Beneficial effects and improved survival in rodent models of septic shock with S-methylisothiourea sulfate, a potent and selective inhibitor of inducible nitric oxide synthase. Proc Natl Acad Sci U S A 1994: 91: 12472-12476.
145. Smith D J, Simmons M L. Transdermal delivery of nitric oxide from diazeniumdiolates. J Controlled Release 1998: 51: 153-159.
146. Hardwick J B, Tucker A T, Wilks M, Johnston A, Benjamin N. A novel method for the delivery of nitric oxide therapy to the skin of human subjects using a semi-permeable membrane. Clin Sci (Lond) 2001: 100 (4): 395-400.
147. Ross R, Reske-Kunz A B. The role of NO in contact hypersensitivity. Int Immunopharmacol 2001: 1: 1469-1478.
148. Salvemini D, Wang Z Q, Stern M K, Currie M G, Misko T P. Peroxynitrite decomposition catalysts: Therapeutics for peroxynitrite-mediated pathology. Proc Natl Acad Sci U S A 1998: 95: 2659-2663.
149. Ferdinandy P, Danial H, Ambrus I, Rothery R A, Schulz R. Peroxynitrite is a major contributor to cytokine-induced myocardial contractile failure. Circ Res 2000: 87: 241-247.
150. Cuzzocrea S, Misko T P, Costantino G et al. Beneficial effects of peroxynitrite decomposition catalyst in a rat model of splanchnic artery occlusion and reperfusion. FASEB J 2000: 14: 1061-1072.
151. Ormerod A D, Dwyer C M, Reid A, Copeland P, Thompson W D. Inducible nitric oxide synthase demonstrated in allergic and irritant contact dermatitis. Acta Derm Venereol 1997: 77: 436-440.
152. Morita H, Semma M, Hori M, Kitano Y. Clinical application of nitric oxide synthase inhibitor for atopic dermatitis. Int J Dermatol 1995: 34: 294-295.
153. Rowe A, Farrell A M, Bunker C B. Constitutive endothelial and inducible nitric oxide synthase in inflammatory dermatoses. Br J Dermatol 1997: 136: 18-23.
154. Becherel P A, Chosidow O, Le Goff L et al. Inducible nitric oxide synthase and proinflammatory cytokine expression by human keratinocytes during acute urticaria. Mol Med 1997: 3: 686-694.
155. Bruch-Gerharz D, Fehsel K, Suschek C, Michel G, Ruzicka T, Kolb-Bachofen V. A proinflammatory activity of interleukin 8 in human skin: Expression of the inducible nitric oxide synthase in psoriatic lesions and cultured keratinocytes. J Exp Med 1996: 184: 2007-2012.
156. Sakai M, Shimizu Y, Nagatsu I, Ueda H. Immunohistochemical localization of NO synthases in normal human skin and psoriatic skin. Arch Dermatol Res 1996: 288: 625-627.
157. Kuhn A, Fehsel K, Lehmann P, Krutmann J, Ruzicka T, Kolb-Bachofen V. Aberrant timing in epidermal expression of inducible nitric oxide synthase after UV irradiation in cutaneous lupus erythematosus. J Invest Dermatol 1998: 111: 149-153.
158. Belmont H M, Levartovsky D, Goel A et al. Increased nitric oxide production accompanied by the up-regulation of inducible nitric oxide synthase in vascular endothelium from patients with systemic lupus erythematosus. Arthritis Rheum 1997: 40: 1810-1816.
159. Andersen G N, Caidahl K, Kazzam E et al. Correlation between increased nitric oxide production and markers of endothelial activation in systemic sclerosis: Findings with the soluble adhesion molecules E-selectin, intercellular adhesion molecule 1, and vascular cell adhesion molecule 1. Arthritis Rheum 2000: 43: 1085-1093.
160. Yamamoto T, Katayama I, Nishioka K. Nitric oxide production and inducible nitric oxide synthase expression in systemic sclerosis. J Rheumatol 1998: 25: 314-317.
161. Mulligan M S, Hevel J M, Marletta M A, Ward P A. Tissue injury caused by deposition of immune complexes is 1-arginine dependent. Proc Natl Acad Sci U S A 1991: 88: 6338-6342.
162. Mulligan M S, Moncada S, Ward P A. Protective effects of inhibitors of nitric oxide synthase in immune complex-induced vasculitis. Br J Pharmacol 1992: 107: 1159-1162.
163. Benrath J, Zimmermann M, Gillardon F. Substance P and nitric oxide mediate would healing of ultraviolet photodamaged rat skin: Evidence for an effect of nitric oxide on keratinocyte proliferation. Neurosci Lett 1995: 200: 17-20.
164. Thornton F J, Schaffer M R, Witte M B et al. Enhanced collagen accumulation following direct transfection of the inducible nitric oxide synthase gene in cutaneous wounds. Biochem Biophys Res Commun 1998: 246: 654-659.
165. Adb-El-Aleem S A, Ferguson M W, Appleton I et al. Expression of nitric oxide synthase isoforms and arginase in normal human skin and chronic venous leg ulcers. J Pathol 2000: 191: 434-442.
166. Jude E B, Boulton A J, Ferguson M W, Appleton I. The role of nitric oxide synthase isoforms and arginase in the pathogenesis of diabetic foot ulcers: Possible modulatory effects by transforming growth factor beta 1. Diabetologia 1999: 42: 748-757.
167. Preiser J C, Reper P, Vlasselaer D et al. Nitric oxide production is increased in patients after burn injury. J Trauma 1996: 40: 368-371.
168. Paulsen S M, Wurster Sh, Nanney L B. Expression of inducible nitric oxide synthase in human burn wounds. Would Repair Regen 1998: 6: 142-148.
169. Stenger S, Thuring H, Rollinghoff M, Bogdan C. Tissue expression of inducible nitric oxide synthase is closely associated with resistance to Leishmania major. J Exp Med 1994: 180: 783-793.
170. Stenger S, Donhauser N, Thuring H, Rollinghoff M, Bogdan C. Reactivation of latent Leishmaniasis by inhibition of inducible nitric oxide synthase. J Exp Med 1996: 183: 1501-1514.
171. Khanolkar-Young S, Snowdon D, Lockwood D N. Immunocytochemical localization of inducible nitric oxide synthase and transforming growth factor-beta (TGF-beta) in leprosy lesions. Clin Exp Immunol 1998: 113: 438-442.